George Shaw, MD
Clinical Cardiac Electrophysiology · Pittsburgh, PANPI 1174757827
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (55.3%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 26 manufacturers reported payments, led by Medical Device Business Services, Inc. at 43.6% of the total. Reporting peaked in 2024 at $35,880 and has fallen 82.8% since, to $6,187 in 2025.
Across 311 payments — averaging $394.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$53K
- Impulse Dynamics (USA) Inc.$34K
- Boston Scientific$14K
- Biosense Webster, Inc.$8K
- Sanofi-aventis U.S. LLC$5K
- Abbott$4K
- plus $6K from 20 others
Across 11 payments — averaging $3460.23 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Impulse Dynamics (USA) Inc.$38K
What the payments were for
- Consulting fees$67,95755%
- Speaking & faculty fees$37,25030%
- Travel & lodging$6,0535%
- Food & beverage$11,5559%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 38 | $53,493 |
| Impulse Dynamics (USA) Inc. | 62 | $33,587 |
| Boston Scientific | 24 | $13,527 |
| Biosense Webster, Inc. | 56 | $7,815 |
| Sanofi-aventis U.S. LLC | 1 | $4,808 |
| Abbott | 42 | $3,903 |
| Medtronic(2 entities) | 45 | $2,466 |
| Altathera Pharmaceuticals LLC | 4 | $1,014 |
| Elutia, Inc. | 4 | $636 |
| Biotronik Inc. | 2 | $474 |
| Johnson & Johnson | 7 | $199 |
| GE HealthCare | 1 | $199 |
| Pfizer | 6 | $108 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $98 |
| Volta Medical Inc | 1 | $97 |
| E.r. Squibb & Sons, L.L.C. | 5 | $92 |
| Cardiva Medical, Inc. | 2 | $64 |
| Abiomed | 2 | $42 |
| Angiodynamics, Inc. | 1 | $36 |
| ZOLL Respicardia, Inc. | 1 | $32 |
| Irhythm Technologies, Inc. | 1 | $27 |
| Novartis | 1 | $23 |
| Philips North America LLC | 1 | $21 |
| Amgen | 1 | $20 |
| Terumo Medical Corporation | 1 | $18 |
| Cardiovascular Systems Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Carto 3$59,485
- OPTIMIZER$54,616
- GENERAL - THERAPIES$12,895
- OPTIMIZER SMART SYSTEM$5,447
- MULTAQ$4,808
- AVEIR$2,072
- EVERA MRI XT DR SURESCAN$1,036
- Sotalol Hydrochloride$1,000
- Accent Pacemaker$700
- ECM Patch,Pouch$604
- AFFERA MAPPING SYSTEM$295
- Carto 3 System$214
- Ensite Cardiac Mapping System$199
- MUSE$199
- Claria MRI$134
- COBALT DR MRI SURESCAN$131
- XARELTO$116
- Watchman$114
- EMBLEM$111
How this compares
$122,815 in reported general payments places this provider in the 85th percentile of 201 clinical cardiac electrophysiology providers in Pennsylvania.
See all clinical cardiac electrophysiology providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 116 | $128,161 |
| XareltoRivaroxaban | 28 | $39,346 |
| Droxidopa | 12 | $24,770 |
| Flecainide Acetate | 69 | $4,435 |
| SotalolSotalol Hcl | 139 | $2,473 |
| Mexiletine Hcl | 17 | $1,544 |
| Propafenone Hcl ErPropafenone Hcl | 12 | $1,100 |
| Amiodarone Hcl | 40 | $778 |
| Metoprolol Succinate | 47 | $728 |
| Midodrine Hcl | 12 | $447 |
| Carvedilol | 17 | $216 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $108 | $128,161116 claims |
| Johnson & JohnsonXarelto | $199 | $39,34628 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 201 clinical cardiac electrophysiology providers in Pennsylvania.
Other clinical cardiac electrophysiology in Pittsburgh
- John ChenaridesPittsburgh$750K
- Joshua SilversteinPittsburgh$557K
- Amit ThosaniPittsburgh$341K
- Nathan EstesPittsburgh$96K
- Krishna KancharlaPittsburgh$83K
- Samir SabaPittsburgh$55K
- Konstantinos AronisPittsburgh$51K
- Virginia SinglaPittsburgh$37K
- Alaaeldin ShalabyPittsburgh$34K
- Seth WorleyLancaster$3.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.